Office of the Secretary; Notice of Meetings, 18305-18306 [2017-07739]
Download as PDF
<![CDATA[
Federal Register / Vol. 82, No. 73 / Tuesday, April 18, 2017 / Notices
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute on Deafness and
Other Communication Disorders;
Notice of Meeting
sradovich on DSK3GMQ082PROD with NOTICES
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of a meeting of the
National Deafness and Other
Communication Disorders Advisory
Council.
The meeting will be open to the
public as indicated below, with
attendance limited to space available.
Individuals who plan to attend and
need special assistance, such as sign
language interpretation or other
reasonable accommodations, should
notify the Contact Person listed below
in advance of the meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications
and/or contract proposals and the
discussions could disclose confidential
trade secrets or commercial property
such as patentable material, and
personal information concerning
individuals associated with the grant
applications and/or contract proposals,
the disclosure of which would
constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Deafness and
Other Communication Disorders Advisory
Council.
Date: May 19, 2017.
Closed: 8:30 a.m. to 9:40 a.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Building 31, Conference Room 6, 31 Center
Drive, Bethesda, MD 20892.
Open: 9:40 a.m. to 2:00 p.m.
Agenda: Staff reports on divisional,
programmatic, and special activities.
Place: National Institutes of Health,
Building 31, Conference Room 6, 31 Center
Drive, Bethesda, MD 20892.
Contact Person: Craig A. Jordan, Ph.D.,
Director, Division of Extramural Activities,
NIDCD, NIH, Room 8345, MSC 9670, 6001
Executive Blvd., Bethesda, MD 20892–9670,
301–496–8693, jordanc@nidcd.nih.gov.
Any interested person may file written
comments with the committee by forwarding
the statement to the Contact Person listed on
this notice. The statement should include the
name, address, telephone number and when
applicable, the business or professional
affiliation of the interested person.
In the interest of security, NIH has
instituted stringent procedures for entrance
onto the NIH campus. All visitor vehicles,
including taxicabs, hotel, and airport shuttles
VerDate Sep<11>2014
16:55 Apr 17, 2017
Jkt 241001
will be inspected before being allowed on
campus. Visitors will be asked to show one
form of identification (for example, a
government-issued photo ID, driver’s license,
or passport) and to state the purpose of their
visit.
Information is also available on the
Institute’s/Center’s home page: https://
www.nidcd.nih.gov/about/Pages/AdvisoryGroups-and-Review-Committees.aspx, where
an agenda and any additional information for
the meeting will be posted when available.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.173, Biological Research
Related to Deafness and Communicative
Disorders, National Institutes of Health, HHS)
Dated: April 12, 2017.
Sylvia L. Neal,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2017–07735 Filed 4–17–17; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of Biomedical
Imaging and Bioengineering; Notice of
Closed Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
Biomedical Imaging and Bioengineering
Special Emphasis Panel; MSM Program
Review (2017/10).
Date: June 6, 2017.
Time: 10:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, Two
Democracy Plaza, 6707 Democracy
Boulevard, Suite 920, Bethesda, MD 20892
(Virtual Meeting).
Contact Person: Manana Sukhareva, Ph.D.,
Scientific Review Officer, National Institute
of Biomedical Imaging and Bioengineering,
National Institutes of Health, 6707
Democracy Boulevard, Suite 959, Bethesda,
MD 20892, (301) 451–3397, sukharem@
mail.nih.gov.
PO 00000
Frm 00029
Fmt 4703
Sfmt 4703
18305
Dated: April 12, 2017.
David Clary,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2017–07734 Filed 4–17–17; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Office of the Secretary; Notice of
Meetings
Pursuant to section 10(a) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of meetings of the Task
Force on Research Specific to Pregnant
Women and Lactating Women.
The meetings will be open to the
public, with attendance limited to space
available. Individuals who plan to
attend and need special assistance, such
as sign language interpretation or other
reasonable accommodations, should
notify the Contact Person listed below
in advance of the meeting.
Name of Committee: Task Force on
Research Specific to Pregnant Women and
Lactating Women.
Date: August 21–22, 2017.
Time: 8:00 a.m. to 5:30 p.m.
Agenda: The Task Force is charged with
providing advice and guidance to the
Secretary of HHS, regarding Federal activities
related to identifying and addressing gaps in
knowledge and research regarding safe and
effective therapies for pregnant women and
lactating women, including the development
of such therapies and the collaboration on
and coordination of such activities.
Place: National Institutes of Health,
Building 31, C-Wing, Conference Rm. 6, 31
Center Drive, Bethesda, MD 20892.
Contact Person: Ms. Lisa Kaeser, Executive
Secretary, Eunice Kennedy Shriver National
Institute of Child Health and Human
Development, 31 Center Drive, Room 2A03,
MSC 2425, Bethesda, MD 20892, (301) 496–
0536, kaeserl@mail.nih.gov.
Name of Committee: Task Force on
Research Specific to Pregnant Women and
Lactating Women.
Date: November 6–7, 2017.
Time: 8:00 a.m. to 5:30 p.m.
Agenda: The Task Force is charged with
providing advice and guidance to the
Secretary of HHS, regarding Federal activities
related to identifying and addressing gaps in
knowledge and research regarding safe and
effective therapies for pregnant women and
lactating women, including the development
of such therapies and the collaboration on
and coordination of such activities.
Place: National Institutes of Health,
Conference Rm. C–D, 6001 Executive Blvd.,
Rockville, MD 20852.
Contact Person: Ms. Lisa Kaeser, Executive
Secretary, Eunice Kennedy Shriver National
Institute of Child Health and Human
E:\FR\FM\18APN1.SGM
18APN1
18306
Federal Register / Vol. 82, No. 73 / Tuesday, April 18, 2017 / Notices
Development, 31 Center Drive, Room 2A03,
MSC 2425, Bethesda, MD 20892, (301) 496–
0536, kaeserl@mail.nih.gov.
Any interested person may file written
comments with the committee by forwarding
the statement to the Contact Person listed on
this notice. The statement should include the
name, address, telephone number and when
applicable, the business or professional
affiliation of the interested person.
In the interest of security, NIH has
instituted stringent procedures for entrance
onto the NIH campus. All visitor vehicles,
including taxicabs, hotel, and airport shuttles
will be inspected before being allowed on
campus. Visitors will be asked to show one
form of identification (for example, a
government-issued photo ID, driver’s license,
or passport) and to state the purpose of their
visit.
Dated: April 12, 2017.
Michelle Trout,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2017–07739 Filed 4–17–17; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Heart, Lung, and Blood
Institute; Notice of Closed Meeting
sradovich on DSK3GMQ082PROD with NOTICES
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Heart, Lung,
and Blood Institute Special Emphasis Panel;
Genetic Basis and/or Omics Phenotypes of
Heart, Lung and Blood Disorders.
Date: May 12, 2017.
Time: 8:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: Residence Inn Bethesda, 7335
Wisconsin Avenue, Bethesda, MD 20814.
Contact Person: Chang Sook Kim, Ph.D.,
Scientific Review Officer, Office of Scientific
Review/DERA, National Heart, Lung, and
Blood Institute, 6701 Rockledge Drive, Room
7188, Bethesda, MD 20892–7924, 301–435–
0287, carolko@mail.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.233, National Center for
Sleep Disorders Research; 93.837, Heart and
VerDate Sep<11>2014
16:55 Apr 17, 2017
Jkt 241001
Vascular Diseases Research; 93.838, Lung
Diseases Research; 93.839, Blood Diseases
and Resources Research, National Institutes
of Health, HHS)
Dated: April 12, 2017.
Michelle Trout,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2017–07740 Filed 4–17–17; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of Diabetes and
Digestive and Kidney Diseases; Notice
of Closed Meetings
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
Diabetes and Digestive and Kidney Diseases
Special Emphasis Panel; NIDDK Central
Biorepositories Non-renewable Sample
Access (X01) PAR–14–301.
Date: May 11, 2017.
Time: 1:00 p.m. to 2:30 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, Two
Democracy Plaza, 6707 Democracy
Boulevard, Bethesda, MD 20892 (Telephone
Conference Call).
Contact Person: Najma Begum, Ph.D.,
Scientific Review Officer, Review Branch,
DEA, NIDDK, National Institutes of Health,
Room 7349, 6707 Democracy Boulevard,
Bethesda, MD 20892–5452, (301) 594–8894,
begumn@niddk.nih.gov.
Name of Committee: National Institute of
Diabetes and Digestive and Kidney Diseases
Special Emphasis Panel; PAR–16–034:
NIDDK Ancillary Studies to Major Ongoing
Clinical Studies (R01).
Date: May 15, 2017.
Time: 2:00 p.m. to 4:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, Two
Democracy Plaza, 6707 Democracy
Boulevard, Bethesda, MD 20892 (Telephone
Conference Call).
Contact Person: Najma Begum, Ph.D.,
Scientific Review Officer, Review Branch,
PO 00000
Frm 00030
Fmt 4703
Sfmt 4703
DEA, NIDDK, National Institutes of Health,
Room 7349, 6707 Democracy Boulevard,
Bethesda, MD 20892–5452, (301) 594–8894,
begumn@niddk.nih.gov.
Name of Committee: National Institute of
Diabetes and Digestive and Kidney Diseases
Special Emphasis Panel; NIDDK Diabetes
Research Centers (P30).
Date: May 24–25, 2017.
Time: 8:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: DoubleTree by Hilton, Ballroom C,
8120 Wisconsin Avenue, Bethesda, MD
20814.
Contact Person: Najma Begum, Ph.D.,
Scientific Review Officer, Review Branch,
DEA, NIDDK, National Institutes of Health,
Room 7349, 6707 Democracy Boulevard,
Bethesda, MD 20892–5452, (301) 594–8894,
begumm@niddk.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.847, Diabetes,
Endocrinology and Metabolic Research;
93.848, Digestive Diseases and Nutrition
Research; 93.849, Kidney Diseases, Urology
and Hematology Research, National Institutes
of Health, HHS)
Dated: April 12, 2017.
David Clary,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2017–07736 Filed 4–17–17; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Request for Information on Input on
Opportunities of Engagement of
External Stakeholders With the
‘‘Illuminating the Druggable Genome’’
(IDG) Program
NIH seeks input from the
biomedical research community,
biotechnology and pharmaceutical
companies and other members of the
public on interest and opportunities of
engagement with the Illuminating the
Druggable Genome (IDG) Program. The
purpose of this Request for Information
(RFI) is to identify and obtain comments
on strategies for sharing potential data,
tools, and other resources of common
interest generated by the IDG Program
and by external stakeholders to
maximize the impact of the IDG
Program.
DATES: The IDG Program Request for
Information is open for public comment
for a period of 30 days. Comments must
be received by May 18, 2017 to ensure
consideration. After the public comment
period has closed, the comments
received by the IDG Program will be
considered in a timely manner by the
National Center for Advancing
SUMMARY:
E:\FR\FM\18APN1.SGM
18APN1
]]>Agencies
[Federal Register Volume 82, Number 73 (Tuesday, April 18, 2017)]
[Notices]
[Pages 18305-18306]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2017-07739]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
Office of the Secretary; Notice of Meetings
Pursuant to section 10(a) of the Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is hereby given of meetings of the Task
Force on Research Specific to Pregnant Women and Lactating Women.
The meetings will be open to the public, with attendance limited to
space available. Individuals who plan to attend and need special
assistance, such as sign language interpretation or other reasonable
accommodations, should notify the Contact Person listed below in
advance of the meeting.
Name of Committee: Task Force on Research Specific to Pregnant
Women and Lactating Women.
Date: August 21-22, 2017.
Time: 8:00 a.m. to 5:30 p.m.
Agenda: The Task Force is charged with providing advice and
guidance to the Secretary of HHS, regarding Federal activities
related to identifying and addressing gaps in knowledge and research
regarding safe and effective therapies for pregnant women and
lactating women, including the development of such therapies and the
collaboration on and coordination of such activities.
Place: National Institutes of Health, Building 31, C-Wing,
Conference Rm. 6, 31 Center Drive, Bethesda, MD 20892.
Contact Person: Ms. Lisa Kaeser, Executive Secretary, Eunice
Kennedy Shriver National Institute of Child Health and Human
Development, 31 Center Drive, Room 2A03, MSC 2425, Bethesda, MD
20892, (301) 496-0536, kaeserl@mail.nih.gov.
Name of Committee: Task Force on Research Specific to Pregnant
Women and Lactating Women.
Date: November 6-7, 2017.
Time: 8:00 a.m. to 5:30 p.m.
Agenda: The Task Force is charged with providing advice and
guidance to the Secretary of HHS, regarding Federal activities
related to identifying and addressing gaps in knowledge and research
regarding safe and effective therapies for pregnant women and
lactating women, including the development of such therapies and the
collaboration on and coordination of such activities.
Place: National Institutes of Health, Conference Rm. C-D, 6001
Executive Blvd., Rockville, MD 20852.
Contact Person: Ms. Lisa Kaeser, Executive Secretary, Eunice
Kennedy Shriver National Institute of Child Health and Human
[[Page 18306]]
Development, 31 Center Drive, Room 2A03, MSC 2425, Bethesda, MD
20892, (301) 496-0536, kaeserl@mail.nih.gov.
Any interested person may file written comments with the
committee by forwarding the statement to the Contact Person listed
on this notice. The statement should include the name, address,
telephone number and when applicable, the business or professional
affiliation of the interested person.
In the interest of security, NIH has instituted stringent
procedures for entrance onto the NIH campus. All visitor vehicles,
including taxicabs, hotel, and airport shuttles will be inspected
before being allowed on campus. Visitors will be asked to show one
form of identification (for example, a government-issued photo ID,
driver's license, or passport) and to state the purpose of their
visit.
Dated: April 12, 2017.
Michelle Trout,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2017-07739 Filed 4-17-17; 8:45 am]
BILLING CODE 4140-01-P
